Bellicum Pharmaceuticals, Inc. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d6f59535-8078-46fa-a9fa-92c0d8cb841f/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-27.0M | 2022-01-01 – 2022-12-31 | evidence 0001628280-23-010145 |
| FY 2021 | $-24.9M | 2021-01-01 – 2021-12-31 | evidence 0001628280-22-007196 |
| FY 2020 | $-51.7M | 2020-01-01 – 2020-12-31 | evidence 0001628280-21-006164 |
| FY 2019 | $-87.4M | 2019-01-01 – 2019-12-31 | evidence 0001358403-20-000007 |
| FY 2018 | $-95.5M | 2018-01-01 – 2018-12-31 | evidence 0001358403-19-000038 |
| FY 2017 | $-87.4M | 2017-01-01 – 2017-12-31 | evidence 0001358403-18-000037 |
| FY 2016 | $-68.4M | 2016-01-01 – 2016-12-31 | evidence 0001358403-17-000050 |
| FY 2015 | $-49.1M | 2015-01-01 – 2015-12-31 | evidence 0001358403-16-000158 |
| FY 2014 | $-57.8M | 2014-01-01 – 2014-12-31 | evidence 0001358403-16-000158 |
| FY 2013 | $-7.9M | 2013-01-01 – 2013-12-31 | evidence 0001358403-16-000158 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Bellicum Pharmaceuticals, Inc. — all facts · Revenue · Net Income